Ferring Pharmaceuticals acquiring Gameto for up to $1.38bn
Swiss pharmaceutical group Ferring Pharmaceuticals has entered into a definitive agreement to acquire New York-based biotechnology company Gameto in a transaction valued at up to $1.38bn. The acquisition represents a major strategic expansion for Ferring in its core therapeutic area of reproductive medicine and maternal health. The transaction features a structured payment system that includes an upfront payment alongside substantial…